Financial reports
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
30 Nov 22
10-Q
2022 Q2
Quarterly report
30 Nov 22
10-Q
2022 Q1
Quarterly report
30 Nov 22
10-K
2021 FY
Annual report
3 Nov 22
10-Q
2021 Q3
Quarterly report
3 Nov 22
Current reports
8-K
SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System
29 Apr 24
8-K
SS Innovations International Announces Q1 2024 Company Updates
22 Apr 24
8-K
Other Events
12 Mar 24
8-K
Unregistered Sales of Equity Securities
15 Feb 24
8-K
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference
1 Feb 24
8-K
Other Events
26 Jan 24
8-K
SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar
25 Jan 24
8-K
SS Innovations Achieves Significant Milestones in 2023
8 Jan 24
8-K
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
26 Dec 23
8-K
Regulation FD Disclosure
4 Dec 23
Registration and prospectus
D
$4.00 mm in debt / options, sold $2.45 mm, 5 investors
27 Feb 24
S-1
IPO registration
14 Feb 24
8-A12G
Registration of securities
1 Nov 23
S-1
IPO registration
2 Oct 19
POS AM
Prospectus update (post-effective amendment)
7 Dec 18
D
$542.26K in equity, sold $542.26K, 26 investors
17 Oct 17
S-1/A
IPO registration (amended)
13 Jul 17
S-1/A
IPO registration (amended)
20 Jun 17
S-1/A
IPO registration (amended)
11 May 17
S-1
IPO registration
14 Feb 17
Proxies
No filings
Other
SEC STAFF ACTION
SEC staff action: Order
1 Sep 22
UPLOAD
Letter from SEC
9 Jul 19
CORRESP
Correspondence with SEC
3 Jul 19
UPLOAD
Letter from SEC
27 Jun 19
EFFECT
Notice of effectiveness
21 Dec 18
EFFECT
Notice of effectiveness
31 Jul 17
CORRESP
Correspondence with SEC
27 Jul 17
CORRESP
Correspondence with SEC
26 Jul 17
UPLOAD
Letter from SEC
10 Jul 17
CORRESP
Correspondence with SEC
20 Jun 17
Ownership
4
SUDHIR SRIVASTAVA
15 Feb 24
SC 13G
MOLL FREDERIC H
14 Feb 24
SC 13G
SRIVASTAVA SUDHIR
9 Feb 24
4
SUDHIR SRIVASTAVA
29 Nov 23
4
Kumar Sethi Anup
29 Nov 23
4
Pascual Srivastava Vishwajyoti
29 Nov 23
4
Barry F Cohen
29 Nov 23
4
Barry F Cohen
13 Nov 23
3
Pascual Srivastava Vishwajyoti
9 Nov 23
3
SUDHIR SRIVASTAVA
9 Nov 23